|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.955 SEK | +2.25% |
|
-26.12% | -61.42% |
| Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
| Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
Oncopeptides AB (publ) announced that Henrik Bergentoft on November 13, 2023 takes office as the company´s new Chief Financial Officer.
| 1st Jan change | Capi. | |
|---|---|---|
| -61.42% | 26.62M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ONCOPEPTIDES AB 
